按技术、应用、最终用户和地区分類的药物基因体学市场

2025 年全球药物基因体学市场规模估计为 192.4 亿美元，预计到 2032 年将达到 422.9 亿美元，2025 年至 2032 年的复合年增长率为 11.9%。

市场占有率。

药物基因体学是科学的一个分支，分析基因如何影响人类对药物的反应。其原理是每个人的基因组成都会影响身体的代谢方式和对药物的反应。随着基因筛检和检测技术的发展，药物基因体学旨在开发考虑到患者个体基因特征的个人化药物配方方法。这使得能够根据患者的特定需求更有效地选择药物，同时减少试验的组合和副作用。随着越来越多的医疗保健系统认识到这种方法在优化药物治疗结果方面的临床实用性，全球药物基因体学市场预计将在未来几年大幅增长。

市场动态

全球药物基因体学市场受到副作用增加、个人化医疗需求不断增长以及伴同性诊断的广泛采用等因素的推动。此外，製药公司不断增加利用药物基因体学方法开发标靶治疗的研发支出也推动了市场的成长。然而，缺乏临床检验和基因检测标准化，阻碍了其在临床实践中的广泛应用。与基因筛检相关的资料隐私和道德问题进一步阻碍了市场扩张。将药物基因组学测试和分析纳入药物临床测试和监管核准流程是有机会。价格合理的药物基因体学诊断试剂套件和服务的开发，特别是在渗透率较低的新兴市场，也将为市场成长提供途径。

研究的主要特点

• 本报告对全球药物基因体学市场进行了详细分析，并展示了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），以 2024 年为基准年。
• 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
• 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球药物基因体学市场的主要企业。
• 主要企业包括赛默飞世尔科技公司 (Thermo Fisher Scientific Inc.)、罗氏公司 (F. Hoffmann-La Roche Ltd.)、Pharmigene、雅培 (Abbott)、安捷伦科技公司 (Agilent Technologies, Inc.)、QIAGEN、通用电气医疗集团 (GE HealthCare)、Empire Inc. Myriad Genetics, Inc.、Illumina, Inc.、Macrogen, Inc.、BGI Genomics、Eurofins Scientific、MapMyGenome 和 Invitae Corporation。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球药物基因体学市场迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过分析全球药物基因体学市场所使用的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 监管情景
• 製造商收益
• 收购和合作场景
• 产品发布/核准
• 资金筹措和投资
• PEST分析
• 波特的分析

第 4 章。

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020 年至 2032 年全球药物基因体学市场（按技术划分）（十亿美元）

• 介绍
• DNA序列分析
• 微阵列
• 聚合酵素链锁反应
• 电泳
• 质谱分析
• 其他的

6. 全球药物基因体学市场，依应用划分，2020-2032 年（十亿美元）

• 介绍
• 心血管疾病
• 感染疾病
• 肿瘤学
• 神经系统疾病
• 疼痛管理
• 其他的

7. 2020-2032 年全球药物基因体学市场（按最终用户划分）（十亿美元）

• 介绍
• 医院和诊所
• 研究和学术机构
• 诊断实验室
• 其他的

8. 2020 年至 2032 年全球药物基因体学市场（按地区划分）（十亿美元）

• 介绍
• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第九章 竞争格局

• 公司简介
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Pharmigene
  • Abbott
  • Agilent Technologies, Inc.
  • QIAGEN
  • GE HealthCare
  • Empire Genomics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Oxford Nanopore Technologies plc.
  • PerkinElmer Inc.
  • Myriad Genetics, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • BGI Genomics
  • Eurofins Scientific
  • MapMyGenome
  • Invitae Corporation

第 10 章 分析师观点

• 兴衰
• 一致的机会地图

第 11 章 参考文献与调查方法

• 参考
• 调查方法

Global Pharmacogenomics Market is estimated to be valued at USD 19.24 Bn in 2025 and is expected to reach USD 42.29 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.9% from 2025 to 2032.

Figure. Pharmacogenomics Market Share (%), By Region 2025

Pharmacogenomics is the branch of science that analyzes how genes affect a person's response to medications. It works on the principle that each person's genetic make-up can influence how their body metabolizes and responds to drugs. With advancements in genetic screening and testing technologies, pharmacogenomics aims to develop personalized prescription approaches that factor in patients' individual genetic profiles. This enables the selection of effective medicines tailored to patients' specific needs while reducing trial-and-error prescribing practices and adverse drug reactions. The global pharmacogenomics market is expected to grow significantly in the coming years as more healthcare systems recognize the clinical utility of this approach in optimizing pharmacotherapy outcomes.

Market Dynamics:

The global pharmacogenomics market is driven by factors such as rising incidences of adverse drug reactions, growing need for personalized medicine, and increasing uptake of companion diagnostics. High research and development expenditures by pharmaceutical companies to develop targeted therapies using pharmacogenomics approaches are also fueling the market growth. However, lack of clinical validation and standardization of genetic tests remains a challenge limiting widespread clinical adoption. Data privacy and ethical concerns related to genetic screening further hamper market expansion. Opportunities lie in incorporating pharmacogenomic testing and profiling into drug trials and regulatory approval processes. Developing affordable pharmacogenetic diagnostic kits and services especially for underpenetrated emerging markets also presents an avenue for market growth.

Key Features of the Study:

• This report provides an in-depth analysis of the global pharmacogenomics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global pharmacogenomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Pharmigene, Abbott, Agilent Technologies, Inc., QIAGEN, GE HealthCare, Empire Genomics, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies plc., PerkinElmer Inc. , Myriad Genetics, Inc., Illumina, Inc., Macrogen, Inc. , BGI Genomics, Eurofins Scientific, MapMyGenome, and Invitae Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global pharmacogenomics market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmacogenomics market.

Detailed Segmentation-

• By Technology:
  • DNA Sequencing
  • Microarray
  • Polymerase Chain Reaction
  • Electrophoresis
  • Mass Spectrometry
  • Others
• By Application:
  • Cardiovascular Diseases
  • Infectious Diseases
  • Oncology
  • Neurological Diseases
  • Pain Management
  • Others
• By End User:
  • Hospitals & Clinics
  • Research Institutions and Academic Institutes
  • Diagnostic Laboratories
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Pharmigene
  • Abbott
  • Agilent Technologies, Inc.
  • QIAGEN
  • GE HealthCare
  • Empire Genomics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Oxford Nanopore Technologies plc.
  • PerkinElmer Inc.
  • Myriad Genetics, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • BGI Genomics
  • Eurofins Scientific
  • MapMyGenome
  • Invitae Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Manufacturer Revenue
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Pharmacogenomics Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Pharmacogenomics Market, By Technology, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• DNA Sequencing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Microarray
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Polymerase Chain Reaction
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Electrophoresis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Mass Spectrometry
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Pharmacogenomics Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Cardiovascular Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Infectious Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oncology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurological Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pain Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Pharmacogenomics Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals & Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research Institutions and Academic Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Laboratories
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Pharmacogenomics Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • F. Hoffmann-La Roche Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Pharmigene
  • Abbott
  • Agilent Technologies, Inc.
  • QIAGEN
  • GE HealthCare
  • Empire Genomics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Oxford Nanopore Technologies plc.
  • PerkinElmer Inc.
  • Myriad Genetics, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • BGI Genomics
  • Eurofins Scientific
  • MapMyGenome
  • Invitae Corporation

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"